Jpmorgan Chase & CO Supernus Pharmaceuticals, Inc. Transaction History

Jpmorgan Chase & CO

$1.22 Trillion
Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 253,396 shares of SUPN stock, worth $9.18 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

253,396

Previous 180,278 40.56%

Holding current value

$9.18 Million

Previous $4.82 Million 63.83%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$25.77 - $35.16 $1.88 Million - $2.57 Million	73,118 Added 40.56%	253,396 $7.9 Million
Q2 2024 Aug 12, 2024	SELL	$25.99 - $33.85 $437,567 - $569,898	-16,836 Reduced 8.54%	180,278 $4.82 Million
Q1 2024 May 10, 2024	BUY	$27.11 - $35.17 $1.12 Million - $1.45 Million	41,361 Added 26.56%	197,114 $6.72 Million
Q4 2023 Feb 12, 2024	BUY	$22.72 - $29.68 $498,249 - $650,882	21,930 Added 16.39%	155,753 $4.51 Million
Q3 2023 Nov 14, 2023	SELL	$27.57 - $32.91 $216,727 - $258,705	-7,861 Reduced 5.55%	133,823 $3.69 Million
Q2 2023 Aug 11, 2023	SELL	$29.91 - $38.73 $2.1 Million - $2.71 Million	-70,087 Reduced 33.1%	141,684 $4.26 Million
Q1 2023 May 18, 2023	BUY	$34.93 - $42.03 $2.25 Million - $2.71 Million	64,476 Added 43.77%	211,771 $7.67 Million
Q1 2023 May 11, 2023	SELL	$34.93 - $42.03 $3.34 Million - $4.02 Million	-95,560 Reduced 39.35%	147,295 $5.34 Million
Q4 2022 Feb 13, 2023	BUY	$31.09 - $37.88 $1.01 Million - $1.23 Million	32,449 Added 15.42%	242,855 $8.66 Million
Q3 2022 Nov 14, 2022	SELL	$28.79 - $35.41 $1.23 Million - $1.51 Million	-42,689 Reduced 16.87%	210,406 $7.12 Million
Q2 2022 Aug 11, 2022	BUY	$25.33 - $34.25 $4.61 Million - $6.23 Million	181,830 Added 255.15%	253,095 $7.32 Million
Q1 2022 May 11, 2022	BUY	$28.51 - $32.9 $326,239 - $376,474	11,443 Added 19.13%	71,265 $2.3 Million
Q4 2021 Feb 10, 2022	BUY	$26.37 - $34.22 $183,218 - $237,760	6,948 Added 13.14%	59,822 $1.75 Million
Q3 2021 Nov 12, 2021	BUY	$23.54 - $31.39 $1.24 Million - $1.66 Million	52,874 New	52,874 $1.41 Million

Others Institutions Holding SUPN

# of Institutions

282

Shares Held

60.9M

Call Options Held

27.7K

Put Options Held

11.3K

View Full List

About SUPERNUS PHARMACEUTICALS, INC.

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $1.94B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

More about SUPN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Supernus Pharmaceuticals, Inc. Transaction History